Original articleLaparoscopic fundoplication compared with laparoscopic gastric bypass in morbidly obese patients with gastroesophageal reflux disease
Section snippets
Methods
The University HealthSystem Consortium (UHC) database is an administrative, clinical, and financial database that provides benchmark measures on the use of healthcare resources for the purpose of comparative data analysis. The UHC is an alliance of 101 academic medical centers and 178 of their affiliated hospitals, representing approximately 90% of the nation's nonprofit academic medical centers. The UHC database is a collection of patient-level, discharge-abstracted data from academic health
Results
During the study period, 27,264 morbidly obese patients with GERD underwent either laparoscopic fundoplication (n = 6108) or laparoscopic gastric bypass (n = 21,156) at U.S. academic medical centers. The proportion of women who had undergone laparoscopic gastric bypass was significantly greater than the proportion who had undergone laparoscopic fundoplication (P <.05; Table 1). The proportion of whites was significantly greater, followed by blacks and Hispanics (P <.05). Morbidly obese black
Discussion
The present study analyzed and compared the perioperative safety and other outcomes of 2 different groups of morbidly obese individuals with GERD who had undergone either laparoscopic fundoplication for the treatment of GERD or laparoscopic gastric bypass for the treatment of obesity-related conditions, including GERD. The main finding of the present study was that laparoscopic gastric bypass is as safe as laparoscopic fundoplication for the treatment of GERD and morbid obesity. However,
Conclusion
Within the context of U.S. academic medical centers, the proportion of morbidly obese patients with GERD who underwent laparoscopic fundoplication procedures was low but resulted in significantly greater in-hospital complications. Whether morbidly obese patients with GERD undergo laparoscopic fundoplication for treatment of GERD or laparoscopic gastric bypass for treatment of morbid obesity, the perioperative outcomes of the latter appeared to be superior in terms of perioperative morbidity. A
Disclosures
The authors and the University HealthSystem Consortium database have no conflicts of interests; Dr. Varela has been a consultant for Ethicon, and Dr. Nguyen has been a consultant for Ethicon and Covidien.
References (22)
- et al.
Continued (5-year) follow-up of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease
J Am Coll Surg
(2001) - et al.
Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: randomised clinical trial
Lancet
(2000) - et al.
Effect of gastric bypass on Barrett's esophagus and intestinal metaplasia of the cardia in patients with morbid obesity
J Gastrointest Surg
(2006) Effects of increased intra-abdominal pressure in severe obesity
Surg Clin North Am
(2001)- et al.
Gastroesophageal reflux disease in obese patients: the role of obesity in management
Dis Esophagus
(2006) - et al.
Long-term management of gastro-oesophageal reflux disease with omeprazole or open antireflux surgery: results of a prospective, randomized clinical trial
Eur J Gastroenterol Hepatol
(2000) - et al.
Prospective trial of laparoscopic Nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: seven-year follow-up
J Gastrointest Surg
(2006) - et al.
Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis
Br J Surg
(2007) - et al.
Laparoscopic vs conventional Nissen fundoplication: a prospective randomized study
Surg Endosc
(1997) - et al.
Comparison of laparoscopic and open Nissen fundoplication 2 years after operation: a prospective randomized trial
Surg Endosc
(2000)